Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Atopy and altered T cell functions contribute to Alopecia Areata.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Blocking certain proteins on immune cells may help treat alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Advances in mechanobiology and immunology could lead to scarless wound healing.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Four antibodies were developed to help study hair follicle cell differentiation.

Skin-associated adipocytes help protect the skin from infections by supporting its immune barrier.